EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
66.50
0.00 (0.00%)
At close: Sep 18, 2026
| Market Cap | 119.24M +4.3% |
| Revenue (ttm) | 9.54M -1.8% |
| Net Income | 2.83M +118.1% |
| EPS | 1.59 +119.8% |
| Shares Out | 1.79M |
| PE Ratio | 41.87 |
| Forward PE | n/a |
| Dividend | 2.00 (3.01%) |
| Ex-Dividend Date | Jun 18, 2026 |
| Volume | 30 |
| Open | 66.50 |
| Previous Close | n/a |
| Day's Range | 66.50 - 66.50 |
| 52-Week Range | 59.00 - 69.00 |
| Beta | -0.00 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 21, 2026 |